在医院环境中使用连续血糖监测系统的共识考虑因素和良好实践要点。

Consensus Considerations and Good Practice Points for Use of Continuous Glucose Monitoring Systems in Hospital Settings.

机构信息

Division of Biochemistry, Eastern Ontario Regional Laboratory Association and The Ottawa Hospital, and Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Ontario, Canada.

American Diabetes Association, Arlington, VA.

出版信息

Diabetes Care. 2024 Dec 1;47(12):2062-2075. doi: 10.2337/dci24-0073.

DOI:10.2337/dci24-0073

PMID:39452893

Abstract

Continuous glucose monitoring (CGM) systems provide frequent glucose measurements in interstitial fluid and have been used widely in ambulatory settings for diabetes management. During the coronavirus disease 2019 (COVID-19) pandemic, regulators in the U.S. and Canada temporarily allowed for CGM systems to be used in hospitals with the aim of reducing health care professional COVID-19 exposure and limiting use of personal protective equipment. As such, studies on hospital CGM system use have been possible. With improved sensor accuracy, there is increased interest in CGM usage for diabetes management in hospitals. Laboratorians and health care professionals must determine how to integrate CGM usage into practice. The aim of this consensus guidance document is to provide an update on the application of CGM systems in hospital, with insights and opinions from laboratory medicine, endocrinology, and nursing.

摘要

连续血糖监测（CGM）系统可提供间质液中频繁的血糖测量，已广泛用于门诊环境中的糖尿病管理。在 2019 冠状病毒病（COVID-19）大流行期间，美国和加拿大的监管机构临时允许在医院使用 CGM 系统，旨在减少医护人员 COVID-19 暴露，并限制个人防护设备的使用。因此，有关医院 CGM 系统使用的研究成为可能。随着传感器准确性的提高，人们对在医院使用 CGM 进行糖尿病管理的兴趣日益增加。实验室人员和医疗保健专业人员必须确定如何将 CGM 的使用纳入实践。本共识指导文件的目的是提供有关 CGM 系统在医院中应用的最新信息，其中包含来自检验医学、内分泌学和护理学的见解和意见。